Application 085980
- Type
- ANDA
- Sponsor
- SEBELA IRELAND LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PRAMOSONE | HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE | LOTION;TOPICAL | 1%;1% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A085980-001 | PRAMOSONE | HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE | 1%;1% | LOTION / TOPICAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A085980-001 | PRAMOSONE | 1%;1% | LOTION / TOPICAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A085980-001 | PRAMOSONE | 1%;1% | LOTION / TOPICAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A085980-001 | PRAMOSONE | 1%;1% | LOTION / TOPICAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pramosone | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Sebela Pharmaceuticals Inc. | f207bdff-2f41-4eee-818e-198b6462863e | 2025-11-08 | Adverse reactions | 085980 ANDA085980 54766-729 |
| Pramosone | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Legacy Pharma USA Inc. | ce3dd32c-1262-454e-aacb-880d54596dd3 | 2025-06-09 | Adverse reactions | 085980 ANDA085980 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54766-729 | Pramosone | hydrocortisone acetate and pramoxine hydrochloride | Sebela Pharmaceuticals Inc. | ANDA | Current |